Periodontal Regeneration With or Without Limited Orthodontics for the Treatment of 2â   or 3â  Wall Infrabony Defects by Ogihara, Shigeki & Wang, Hom‐lay
Periodontal Regeneration With
or Without Limited Orthodontics
for the Treatment of 2- or 3-Wall
Infrabony Defects
Shigeki Ogihara* and Hom-Lay Wang†
Background: Limited orthodontics are shown to be effective
in the correction of infrabony defects. Studies have also demon-
strated the efficacy of using enamel matrix derivative (EMD)
with demineralized freeze-dried bone allograft (DFDBA) to treat
infrabony defects. This study aims to compare the clinical effi-
cacy of limited orthodontics combined with EMD/DFDBA in
the treatment of 2- or 3-wall infrabony defects.
Methods: A randomized, parallel clinical trial was conducted
in a private periodontal practice (Tokyo, Japan) between April
2004 and October 2008. Treatment period was 1 year with
a 1-year follow-up. Forty-seven randomized patients, mean
age of 53 – 10.7 years, were allocated into two intervention
groups: ortho/EMD/DFDBA (n = 24) and EMD/DFDBA (n =
23). Each patient had either a 2- or 3-wall infrabony defect of
‡6 mm deep. Probing depth and clinical attachment level were
measured at baseline and 1 year. The primary outcome measure
was absolute change in probing depth and clinical attachment
level from baseline to 1-year follow-up. The secondary outcome
measure was absolute change in open probing attachment level
gain and percentage defect resolution from baseline to 6-month
reentry surgery. Infrabony defects were surgically treated with
EMD and DFDBA 4 weeks before application of orthodontic
extrusive forces. Reentry surgeries were performed at 6 months
after initial surgery.
Results: Forty-seven patients were analyzed. Both treatment
groups showed a significant improvement from baseline with no
significant difference between the groups except for the 2-wall
defects. The ortho/EMD/DFDBA group had statistically signifi-
cant open probing attachment level gain (95% confidence level,
3.18 to 4.36; P = 0.036) compared to the EMD/DFDBA group
(95% confidence level, 2.26 to 3.24) in 2-wall defects.
Conclusion: Although both treatment modalities were effec-
tive in managing 2- or 3-wall infrabonydefects, limitedorthodon-
tics provided an additional benefit to EMD/DFDBA in 2-wall
defects. J Periodontol 2010;81:1734-1742.
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M
echanical stimulation using or-
thodontic extrusive force plays
a critical role in periodontal tis-
sue development.1 In a case report,
Ingber2,3 demonstrated that forced erup-
tion resulted in infrabony defect resolu-
tion accompanied by coronal positioning
of intact connective tissue attachment in
1- and 2-wall infrabony defects. Brown4
too reported that orthodontic treatment
could be successfully used in correcting
an infrabony defect associated with a
mesially inclined molar. Histologic new
bone formation was observed on the ten-
sion side. Corrente et al.5 performed open
flap debridement on teeth with infrabony
defects before applying light continuous
orthodontic forces (7 to 10 g) to close
spaces and intrude pathologically ex-
truded teeth. Mean vertical and horizon-
tal bone fill of approximately 1.38 mm
was found. In addition, overall improve-
ment in clinical attachment level (CAL)
gain and probing depth (PD) reduction
was also obtained. Recently, orthodontic
regenerative combined therapy, which
consisted of tissue regeneration followed
by application of orthodontic extrusive
forces, was proposed to enhance peri-
odontal regeneration of infrabony de-
fects.6 The advantage of this treatment
approach was that new periodontal liga-
ment fiber attachment would form before
orthodontic therapy, hence facilitating
transfer of orthodontic forces to bone.* Private practice, Tokyo, Japan.
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In an animal model, Diedrich et al.7 showed histo-
logic periodontal regeneration of infrabony defects.
Approximately 70% new root cementum formation
with Sharpey’s fibers insertion was observed after
application of enamel matrix proteins and resorb-
able membranes. Ghezzi et al.8 used enamel matrix
derivative (EMD) and bone grafts with collagen
membranes to achieve periodontal regeneration in
human infrabony defects. One year after the regener-
ative therapy, orthodontic forces were applied on the
teeth to realign the dental arch. Significant improve-
ments in PD and CAL were found after guided tissue
regeneration. However, orthodontic therapy did not
further improve these clinical parameters. Therefore,
the authors concluded that orthodontic therapy was
not damaging to regenerated periodontal tissues. In
a case series, a collagen bovine bone mineral was
used to graft vertical defects. Light continuous ortho-
dontic forces were applied toward and through the
infrabony defects 2 weeks after grafting. A mean
CAL gain of 4.67 mm with radiographic bone fill of
2 to 3.17 mm and >70% defect resolution were
achieved despite orthodontically moving teeth through
immature bone.9 This supports the use of tissue re-
generation and orthodontics in the management of in-
frabony defects.
Accelerated osteogenic orthodontics, which in-
volved corticotomy and alveolar bone augmentation
before orthodontic tooth movement, was introduced
by Wilcko et al. in 2001.10 This technique used the
regional acceleratory phenomenon,11 which is a pro-
cess that results in bursts of hard and soft tissue re-
modeling activated through surgical manipulation of
the alveolar bone. Particulate bone graft was subse-
quently placed over the decorticated sites to prevent
bone loss over the roots of the teeth. Therefore, accel-
erated osteogenic orthodontics not only drastically
shortened orthodontic treatment time, but it also
thickened the buccolingual bone width of the teeth
involved.
The literature revealed that timing of the com-
mencement of orthodontic treatment after periodon-
tal surgery ranged from 10 days to 1 year,6,8,9,12-14
primarily caused by heterogeneity of study design in
terms of force application, orthodontic appliance
used, and type and degree of orthodontic movement.
Some studies have also suggested that periodontal
surgery be performed after completion of orthodontic
treatment to provide a more conducive environment
for periodontal regeneration.15,16 As a result, it was
generally recommended that in patients with peri-
odontal disease, orthodontic treatment should start
2 to 6 months after periodontal therapy to allow for
periodontal healing and stabilization.17
Light continuous forces of 5 to 15 g were recom-
mended for efficient tooth movement in a compro-
mised periodontium because heavier forces might
result in further loss of periodontal attachment and
thus an increased crown/root ratio.18 In orthodontic
extrusion of periodontally compromised teeth, con-
stant orthodontic forces that produce an extrusion
rate of £2 mm per month is ideal.19 Histologically,
mineralization of osteoid starts 18 to 21 days after
the surgical procedure, and complete bone matura-
tion takes approximately 100 days.20 Therefore, any
orthodontic tooth movement before 3 months post-
surgery would be moving teeth through immature
bone. Severe root resorption as a result of greater bone
remodeling along the root surface is a major drawback
of moving teeth through immature bone. However,
faster tooth movement could be accomplished.21
Studies on the effectiveness of EMD in periodontal
regeneration have demonstrated promising results.
For example, Harrel et al.22 used EMD to treat infra-
bony defects and found significant PD reduction and
CAL gains that were stable for 6 years. Sculean
et al.23 also demonstrated long-term success with
periodontal regeneration in infrabony defects treated
with EMD. In defects that were unable to contain EMD,
addition of a bone graft (e.g., demineralized freeze-
dried bone allograft [DFDBA]) was successful in re-
generating the periodontal tissues in these infrabony
defects.24,25 Therefore, a combination of EMD and
DFDBA was chosen for this study.
To our knowledge, no study has examined limited
orthodontic treatment with EMD/DFDBA to deter-
mine its ability to treat advanced periodontal disease.
Therefore, the purpose of this study is to compare
the clinical efficacy of EMD/DFDBA with or without
limited orthodontics in the treatment of 2- or 3-wall
infrabony lesions.
MATERIALS AND METHODS
This was a randomized, parallel clinical trial con-
ducted in a private periodontal practice (Tokyo,
Japan) between April 2004 and October 2008.
Forty-seven eligible, consecutive patients with chronic
periodontitis (8 males and 39 females) who required
periodontal treatment were recruited from a private
practice to participate in this study. All patients were
informed of the nature of the study, procedures in-
volved, and potential risks and benefits associated
before providing written informed consent to partici-
pate in this voluntary clinical trial. The inclusion criteria
for this study were as follows: patients with chronic
periodontitis, who had completed initial-phase therapy
that included full-mouth scaling and root planing,
occlusal adjustment where indicated, oral hygiene in-
structions 2 months before enrollment and at reeval-
uation, and a radiographic vertical defect of ‡6 mm
at one or two sites. Smokers or patients who were preg-
nant or lactating were excluded from this study.
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At the time of screening, a comprehensive clinical
and radiographic examination was conducted, in ad-
dition to obtaining a complete medical and dental
history, to identify the target infrabony defect. Each
patient contributed one or two infrabony defects.
In total, 50 infrabony defects were identified in 47
patients.
Using a periodontal probe,‡ PD and CAL of the
target defects were measured and recorded by one cali-
brated examiner (SO) at baseline and 1-year follow-up.
ThePDmeasurement represented thegreatest distance
from gingival margin to base of pocket, whereas CAL
is the corresponding distance from the cemento-
enamel junction, crown, or restoration margin to base
of pocket. The primary outcome measure was abso-
lute change in mean PD reduction and CAL gain from
baseline to 1-year follow-up. The secondary outcome
measure was absolute change in mean open probing
attachment level (OPAL) gain and percentage defect
resolution from initial surgery to 6 months reentry.
All patients rinsed presurgically with 0.12% chlor-
hexidine solution. After topical and local anesthesia,
sulcular incisions were made before a full-thickness
flap was reflected. The target infrabony defects were
completely debrided and root planed with hand and
ultrasonic instruments and subsequently categorized
according to their morphology. The same calibrated
examiner recorded direct measurements of the hard
tissue, termed the ‘‘open probing attachment level.’’
Minocycline solution, which has anticollagenase
activity, was used as a root-conditioning agent for
3 minutes. The surgical site was thoroughly irrigated
with sterile water before application of EMD.§ A
composite graft consisting of DFDBAi mixed with
minocycline and EMD (i.e., 0.25 cc of DFDBA con-
taining 0.3 ml of EMD) were lightly packed into the
infrabony defect until a slight overfill was achieved.
Flaps were reapproximated and sutured to achieve
tension-free primary closure. Horizontal mattress
and single interrupted sutures using a 5-0 monofila-
ment suture¶ were placed to ensure flap adaptation
and closure. The remaining EMD was gently applied
onto the flap margins to enhance soft tissue wound
healing.
Patients were instructed to avoid brushing and
flossing at the surgical site until sutures were removed
7 days post-surgery. Minocycline for 4 days, 100 mg
per day, was prescribed. Patients were seen for post-
operative treatment including plaque debridement,
oral rinse with 0.12% chlorhexidine solution, and re-
inforcement of oral hygiene every week before com-
pletion of a restorative program.
Before patients were randomized, three defects
were excluded because three patients each contrib-
uted two defects. Forty-seven randomized patients
(mean age; 53 – 10.7 years) with 47 2-wall, 3-wall,
or combination infrabony defects of ‡6 mm were allo-
cated into two intervention groups: ortho/EMD/
DFDBA (OED) (n = 24) (Fig. 1) and EMD/DFDBA
only (ED) (n = 23) (Fig. 2). Teeth in the OED group
had extensive subgingival caries and required end-
odontic treatment and orthodontic extrusion before
crown placement to avoid violation of biologic width.
An elastic hook was placed into the root canal of the
target teeth in the OED group by direct bonding for
orthodontic extrusion before initial periodontal re-
generation surgery.
Four weeks after the initial surgery, orthodontic ex-
trusion was initiated in the OED group because it was
thought that the enhanced angiogenesis at the surgi-
cal site might facilitate tooth movement. At this stage,
remarkable soft tissue healing was obtained, espe-
cially in the interproximal area where reepithelializa-
tion was seen in most of the treated cases. Before
orthodontic treatment, an occlusal metal bar (fixed
orthodontic appliance) was directly bonded to the
adjacent teeth to enable orthodontic extrusion and
uprighting/concurrent extrusion of the target tooth.
A light orthodontic force (60 to 120 g) was directed
occlusally or disto-occlusally for 4 weeks. Elastics
were changed every 5 days to provide a constant or-
thodontic force on the target tooth. Excellent oral
hygiene was kept by regular maintenance and rein-
struction. Four weeks after orthodontic extrusion
was completed, temporary stabilization with ligature
and resin was provided. Six months after initial sur-
gery, a reentry surgery was performed and hard tissue
measurements (OPAL) were taken and recorded. The
target teeth were restored after the surgical sites were
healed. The entire treatment period was 1 year. Pri-
mary outcome was absolute change from baseline
to 1-year follow-up (ED group, n = 23; OED group,
n = 24) to prevent the influence of orthodontic fixed
appliance in mean PD reduction and CAL gain. Sec-
ondary outcome was absolute change from initial
surgery to 6 months reentry in mean OPAL gain.
A statistical package#** was used for statistical
analyses. A power analysis was conducted to deter-
mine the sample size required to attain 97% power (a
= 0.050; trials = 2). This means that close to 100%
change would be expected to yield a significant effect.
The primary analysis was intention-to-treat and in-
volved all patients who were recruited. Paired t test
was used to compare the mean PD, CAL, and OPAL
measurements at baseline and 1-year follow-up, with
significance set at P £0.05 and expressed with 95%
‡ Williams probe, Hu-Friedy, Chicago, IL.
§ Emdogain, Straumann, Basel, Switzerland.
i OraGRAFT, LifeNet Health, Virginia Beach, VA.
¶ Ethicon, Johnson & Johnson, Somerville, NJ.
# XLSTAT-Pro, Addinsoft USA, New York, NY.
** Microsoft Office 2007, Microsoft Corporation, Tokyo, Japan.
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confidence intervals (CI). The differences between
initial and postoperative values were analyzed by
Wilcoxon matched-pairs signed-ranked tests and
were also expressed with 95% CI.
RESULTS
Forty-seven eligible patients with chronic periodon-
titis that required periodontal treatment were re-
cruited from a private practice between April 2004
and October 2008. Patients attended from the time
of randomization (baseline) to 1-year follow-up. The
primary analysis was intention-to-treat and involved
all patients who were randomly assigned. No patient
was lost (ED group, n = 23; OED group, n = 24). Base-
line information is presented in Table 1.
There were no statistically significant differences in
baseline clinical parameters between the two treatment
groups (P = 0.434, P = 0.891, P = 0.890 for preoperative
PD, CAL, OPAL, respectively; Table 1). Both treatment
groups had statistically significant PD reduction and
CAL gain compared to baseline (P <0.001). However,
no statistically significant difference was found between
the two treatment groups (Table 2). The same trend was
also noted in OPAL gain and percentage of defect res-
olution. A significant improve-
ment in OPAL from baseline
was observed in both treatment
groups (P <0.001); however, no
difference was found between
the two groups (Table 3).
Interestingly, there was a sta-
tistically significant difference
in OPAL gain between the two
groups for the 2-wall defect
sites. The OED group had sta-
tistically significant OPAL gain
compared to the ED group.
However, the absolute CAL
gain did not reach statistical
significance (P = 0.051; Table
4). For the 3-wall defect sites,
there were no significant differ-
ences between the two treat-
ment groups (Table 5).
DISCUSSION
Overall, this study indicated
that both treatments, EMD
and DFDBA with or without
limited orthodontics, were ef-
fective in the treatment of in-
frabony defects. Within 2-wall
Figure 1.
Combination of limited orthodontics and EMD/DFDBA for the treatment of an intrabony defect. A) Extent
of the intrabony defect demonstrated by the insertion of a periodontal probe. OPAL was >11 mm. B) EMD/
DFDBA were compacted into the intrabony defect. C) Lingual view of initial extrusion at 4 weeks after
initial surgery showed remarkable soft tissue healing, especially the interproximal area through enhancing
angiogenesis. D) Reentry 6 months after initial surgery confirmed complete filling of the intrabony defect
and reestablishment of biologic width. The OPAL was improved from >11 mm to 5 mm (gain of 6+ mm).
Figure 2.
EMD/DFDBA in the treatment of an intrabony defect. A) Extent of the intrabony defect demonstrated by the insertion of a periodontal probe. OPAL was
6 mm. B) EMD/DFDBA were compacted into the intrabony defect. C) Reentry 6 months after initial surgery confirmed complete filling of the intrabony
defect. The OPAL was improved from 6 mm to 3 mm (gain of 3 mm).
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defect sites, the OED group
hadstatisticallysignificantOPAL
gain (95% CI, 3.18 to 4.36; P =
0.036) compared to the ED
group (95% CI, 2.26 to 3.24).
On the contrary, the OED
group had absolute CAL gain
(95% CI, 3.19 to 4.03; P =
0.051) compared to the ED
group (95% CI, 2.93 to 3.57).
It was thus hypothesized that
only OPAL gain was significant
between the two groups be-
cause the measurement of
CAL was dependent on the
free gingival margin level and
identification of the cemento-
enamel junction might be dif-
ficult in some of the cases.
In addition, because no stent
was used, measurement errors
might have occurred.
In the management of 3-wall
infrabony defects, both treat-
ment modalities seemed to
have similar outcomes. This
could possibly be caused by
the defect morphology being
conducive for periodontal re-
generation. A 3-wall infrabony
defect allows for containment
of EMD and DFDBA providing
wound stability, space main-
tenance, and clot stabilization,
hence promoting a favorable
regenerative treatment out-
come.26 As a result, the effect
of orthodontic extrusion on
eliminating these defects was
inconsequential.
The success of periodontal
regeneration is dependent on
four key elements: 1) cells; 2)
appropriate signals; 3) scaf-
fold; and 4) blood supply.27
The establishment of new
vascular networks (angiogen-
esis) is essential for periodon-
tal regeneration because they
are sources of nutrients for
cell growth and homeostasis.
During orthodontic extrusion,
mechanical stresses exerted
onto the alveolar bone led
to activation of angiogenic
growth factors, such as vascular
Table 1.









Average age (years) 53 – 10.7 55.6 – 9.4 50.5 – 11.5
Gender
Female 39 19 20
Male 8 4 4
Lesion (walls)
1-wall 0 0 0
2-wall 21 8 13
3-wall 19 12 7
Combination 7 3 4
Tooth
Incisor 0 0 0
Canine 0 0 0
Premolar 5 2 3
Molar 42 21 21
Jaw
Maxilla 20 11 9
Mandible 27 12 15
PD (mm)* 6.43 – 0.72 6.75 – 1.29
CAL (mm)† 7.26 – 0.96 7.29 – 1.20
No statically significant difference was found on the baseline clinical parameters between the two study groups.
* P = 0.31.
† P = 0.92.
Table 2.
Comparison of Probing Depths and Clinical Attachment
Levels at Baseline and 1-Year Follow-Up Between the Two
Treatment Groups
Parameter (mm) EMD/DFDBA (n = 23) Ortho/EMD/DFDBA (n = 24) P Value
Baseline PD 6.43 – 0.72 6.75 – 1.29
PD at 1 year 2.74 – 0.54 2.54 – 0.51
PD reduction 3.70 – 0.76 4.21 – 1.35 0.12
Change (%)* 57 – 8 61 – 9 0.11
95% CI difference 3.36 to 3.98 3.67 to 4.75
Baseline CAL 7.26 – 0.94 7.29 – 1.20
CAL at 1 year 3.74 – 0.69 3.50 – 0.78
CAL gain 3.50 – 0.79 3.67 – 0.76 0.52
Change (%)* 48 – 7.6 50 – 7.1 0.50
95% CI difference 3.18 to 3.82 3.37 to 3.97
* Both treatment groups resulted in statistically significant PD reduction and CAL gain compared to baseline
(P <0.001).
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endothelial growth factor (VEGF).28 VEGF produc-
tion is one of the major mechanisms by which angio-
genesis is closely linked to osteogenesis during bone
formation and remodeling.29 Kleinheinz et al.30 also
showed that VEGF activation led to more intense
angiogenesis and bone regeneration. Recently, EMD
was found to stimulate angiogenesis directly through
endothelial cells and indirectly through production of
VEGF by periodontal ligament cells.31 In addition, the
use of EMD has been found to have positive effects on
periodontal regeneration, such as promoting peri-
odontal ligament cell proliferation and migration,32
and formation of new bone33
and new cementum.34 EMD
can also enhance granula-
tion tissue formation and
accelerate wound closure
by VEGF expression.31 Fur-
thermore, EMD has also
been demonstrated to pro-
mote soft tissue healing;35
hence, it might protect the
surgical site to ensure an
uneventful healing process.
For all the reasons men-
tioned, EMD was used in
this study to enhance peri-
odontal regeneration in the
infrabony defects.
In this study, 59.6% (28
of 47) of infrabony defects
were 2-wall or combination
defects, whereas 44.7% (21
of 47) were 2-wall defects.
Because of the defect mor-
phology, containment of
purely EMD without a bone
substitute within the defect
would be a challenge be-
cause of the fluid nature of
the material. In addition,
Cortellini and Tonetti36 also
recommended the use of
bone or bone substitutes
in infrabony defects. There-
fore, in this study, an alloge-
neic bone graft (DFDBA)
was chosen because it was
shown to have histologic
evidence of new attachment






outcomes with the use of bioactive agents, such as
EMD, bone, or bone substitutes (e.g., DFDBA and
barrier membranes).40-42 This observation was con-
sistent with the findings of our study where there were
significant improvements in PD and CAL between the
two treatment groups. However, it is important to un-
derstand that there is great heterogeneity among the
studies, and an overestimation of the overall treat-
ment effect is possible.41
Other studies have also used regenerative proce-
dures with orthodontic treatment and achieved fa-
vorable results.6-8 Again, there was variance within
Table 3.
Comparison of Open Probing Attachment Levels at Baseline





(n = 24) P Value
Pretreatment OPAL 7.60 – 1.95 7.40 – 1.92
OPAL at 6-month
reentry
3.39 – 0.84 3.33 – 0.70
Gain of OPAL 4.17 – 1.97 4.29 – 1.40 0.82
Change (%)* 53 – 13 55 – 5.8 0.82
95% CI difference 3.36 to 4.98 3.73 to 4.85
* Both study groups resulted in statistically significant OPAL gain compared to baseline (P <0.001).
Table 4.
Comparison of Probing Depths and Clinical Attachment Levels
of 2-Wall Infrabony Defects at Baseline and 1-Year Follow-Up





(n = 13) P Value
Baseline PD 6.13 – 0.35 6.69 – 1.01
PD at 1 year 2.75 – 0.46 2.69 – 0.48
PD reduction 3.38 – 0.52 4.00 – 0.91
Change (%) 55 – 7.5 59 – 7.3 0.21
95% CI difference 3.02 to 3.74 3.51 to 4.49
Baseline CAL 7.25 – 0.71 7.23 – 1.1
CAL at 1 year 4 – 0.53 3.61 – 0.87
CAL gain 3.25 – 0.46 3.61 – 0.77
Change (%) 45 – 4.6 51 – 8 0.051
95% CI difference 2.93 to 3.57 3.19 to 4.03
Pretreatment OPAL 6.63 – 1.06 7.08 – 1.71
OPAL at 6-month reentry 4 – 1.20 3.31 – 0.75
Gain of OPAL 2.75 – 0.71 3.77 – 1.09
Change (%) 42 – 1.1 53 – 4.8 0.036*
95% CI difference 2.26 to 3.24 3.18 to 4.36
* Ortho/EMD/DFDBA group had statistically significant OPAL gain compared to EMD/DFDBA treated site
(P <0.05).
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the study designs. For example, Ghezzi et al.8 used
EMD only in 3-wall infrabony defects and bone graft
with collagen membrane in 1- and 2-wall defects. In
addition, orthodontic treatment, which involved in-
trusion and bodily tooth movements, commenced
1 year after periodontal surgery, thus allowing time
for healing so the tooth movement would have oc-
curred in mature bone. Our study, on the contrary,
used EMD and DFDBA in both 2- and 3-wall defects,
and orthodontic extrusive forces were applied 1 month
after periodontal surgery. Therefore, orthodontic tooth
movement occurred in immature bone in our study. In
an animal model, Diedrich et al.7 started distalizing
the target tooth with orthodontic forces 1 month after
periodontal regeneration with EMD. Again, the na-
ture of the orthodontic tooth movements was differ-
ent from those used in this study.
Excessive orthodontic extrusive forces exerted on
teeth may cause root resorption and ankylosis.43,44
Determination of the appropriate extrusive forces to
be applied depends on the root morphology, mainly
the root diameter, length, and surface area. Therefore,
if the tooth to be extruded is an incisor, 15 g is sufficient,
whereas 60 g might be needed for a molar.45 If slow ex-
trusion is desired, 30 g of force applied is adequate.46
However, if rapid extrusion is needed, the force ap-
plied should be increased to 50 g.47 In this study,
the orthodontic extrusive forces used ranged from
60 to 120 g because rapid extrusion was desired with
44.7% (21 of 47) of the teeth involved being molars.
In this study, orthodontic
extrusive forces were applied
4 weeks after periodontal re-
generative surgery. However,
it could be speculated that
orthodontic extrusion alone
was sufficient to treat the in-
frabony defects. However,
Nemcovsky et al.48 found
in an animal model that or-
thodontic forces alone were
unable to regenerate com-
pletely the lost periodontium
in infrabony defects because
the apical migration of long
junctional epithelium was un-




ment. On the other hand, or-
thodontic treatment could
be performed any time af-
ter 4 weeks. Ogihara and
Marks6 started orthodontic
extrusion in a case report 8
weeks after periodontal regeneration surgery and
favorable results were obtained at reentry surgery
6 months after. Ghezzi et al.8 performed orthodontic
treatment 1 year after periodontal surgery, and it
was found that orthodontic treatment did not have
a significant influence on the regenerated defect. In
this case, it could be postulated that if orthodontic
treatment was started a long period of time after the
suggested 4 weeks, there might not be significant
changes in the clinical parameters after periodontal
surgery.
Besides root and alveolar bone morphology, the di-
rection of orthodontic tooth movement should also
be considered. Orthodontic tooth movement can be
classified as bodily or tipping tooth movement into
an intrabony defect, moving away from an infrabony
defect including extrusion and uprighting and intrud-
ing migrated elongated teeth into the reduced alveolar
bone. It was found that molar uprighting could poten-
tially lead to reduced levels of periodontal pathogens,
such as Tannerella forsythensis (previously Bacteroides
forsythus), Porphyromonas gingivalis, Prevotella inter-
media, and Aggregatibacter actinomycetemcomitans
(previously Actinobacillus actinomycetemcomitans),
thus improving periodontal health.49 In animal models,
intrusion of teeth to eliminate the infrabony defect led to
periodontal regeneration, degradation, and remodeling
of the bone graft and formation of new woven bone.50,51
There were several shortcomings in this study:
short follow-up period, absence of a control group
Table 5.
Comparison of Probing Depths and Clinical Attachment Levels
of 3-Wall Infrabony Defects at Baseline and 1-Year Follow-Up





(n = 7) P Value
Baseline PD 6.67 – 0.89 7 – 1.91
PD at 1 year 2.58 – 0.51 2.29 – 0.49
PD reduction 4.08 – 0.67 4.71 – 2.14
Change (%) 61 – 0.063 65 – 0.12 0.43
95% CI difference 3.76 to 4.46 3.12 to 6.3
Baseline CAL 7.25 – 1.22 7.57 – 1.61
CAL at 1 year 3.42 – 0.67 3.29 – 0.76
CAL gain 3.83 – 0.83 3.71 – 0.76
Change (%) 53 – 0.061 49 – 0.060 0.26
95% CI difference 3.36 to 4.3 3.15 to 4.27
Pretreatment OPAL 7.83 – 2.24 8 – 2.51
OPAL 6-month reentry 3 – 0.01 3.29 – 0.76
Gain of OPAL 4.75 – 2.14 4.71 – 1.89
Change (%) 58 – 0.11 58 – 0.073 0.928
95% CI difference 3.54 to 5.96 3.31 to 6.11
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where open flap debridement was performed, a defi-
ciency in racial or population diversity because of
a primarily Japanese population, no radiographic
analysis, and lack of stents to facilitate reproducible
measurements.
CONCLUSIONS
This study shows that both treatments, EMD/DFDBA
and ortho/EMD/DFDBA, were effective for the treat-
ment of 2- or 3-wall infrabony defects within the
1-year study period. In 2-wall infrabony defects, use
of limited orthodontics seemed to be effective in
achieving attachment level gains at 6 months. How-
ever, caution is needed when interpreting these re-
sults because of the inherent limitations of the study.
Therefore, more long-term randomized controlled tri-
als are needed.
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T, Papapoulos SE, Löwik CW. Expression of vascular
endothelial growth factors and their receptors during
osteoblast differentiation. Endocrinology 2000;141:
1667-1674.
30. Kleinheinz J, Stratmann U, Joos U, Wiesmann HP.
VEGF-activated angiogenesis during bone regenera-
tion. J Oral Maxillofac Surg 2005;63:1310-1316.
31. Schlueter SR, Carnes DL, Cochran DL. In vitro effects
of enamel matrix derivative on microvascular cells.
J Periodontol 2007;78:141-151.
32. Hoang AM, Oates TW, Cochran DL. In vitro wound
healing responses to enamel matrix derivative.
J Periodontol 2000;71:1270-1277.
33. Yoneda S, Itoh D, Kuroda S, et al. The effects of
enamel matrix derivative (EMD) on osteoblastic cells
in culture and bone regeneration in a rat skull defect.
J Periodontal Res 2003;38:333-342.
34. Sculean A, Stavropoulos A, Berakdar M, Windisch P,
Karring T, Brecx M. Formation of human cementum
following different modalities of regenerative therapy.
Clin Oral Investig 2005;9:58-64.
35. Sculean A, Junker R, Donos N, Windisch P, Brecx M,
Dünker N. Immunohistochemical evaluation of matrix
molecules associated with wound healing following
treatment with an enamel matrix protein derivative in
humans. Clin Oral Investig 2003;7:167-174.
36. Cortellini P, Tonetti MS. Focus on intrabony defects:
Guided tissue regeneration. Periodontol 2000 2000;22:
104-132.
37. Bowers GM, Chadroff B, Carnevale R, et al. Histo-
logic evaluation of new attachment apparatus for-
mation in humans. Part III. J Periodontol 1989;60:
683-693.
38. Bowers GM, Chadroff B, Carnevale R, et al. Histologic
evaluation of new attachment apparatus formation in
humans. Part II. J Periodontol 1989;60:675-682.
39. Bowers GM, Chadroff B, Carnevale R, et al. Histologic
evaluation of new attachment apparatus formation in
humans. Part I. J Periodontol 1989;60:664-674.
40. Esposito M, Grusovin MG, Papanikolaou N, Coulthard
P, Worthington HV. Enamel matrix derivative (Emdo-
gain) for periodontal tissue regeneration in intrabony
defects. A Cochrane Database Systematic Rev 2009;7:
CD003607.
41. Trombelli L, Farina R. Clinical outcomes with bioactive
agents alone or in combination with grafting or guided
tissue regeneration. J Clin Periodontol 2008;35(Suppl.
8):117-135.
42. Venezia E, Goldstein M, Boyan BD, Schwartz Z. The
use of enamel matrix derivative in the treatment of
periodontal defects: A literature review and meta-
analysis. Crit Rev Oral Biol Med 2004;15:382-402.
43. Oesterle LJ, Wood LW. Raising the root. A look at
orthodontic extrusion. J Am Dent Assoc 1991;122:
193-198.
44. Minsk L. Orthodontic tooth extrusion as an adjunct to
periodontal therapy. Compend Contin Educ Dent
2000;21:768-770, 772, 774 passim.
45. Bach N, Baylard JF, Voyer R. Orthodontic extrusion:
Periodontal considerations and applications. J Can
Dent Assoc 2004;70:775-780.
46. Reitan K. Clinical and histologic observations on tooth
movement during and after orthodontic treatment. Am
J Orthod 1967;53:721-745.
47. Bondemark L, Kurol J, Hallonsten AL, Andreasen JO.
Attractive magnets for orthodontic extrusion of crown-
root fractured teeth. Am J Orthod Dentofacial Orthop
1997;112:187-193.
48. Nemcovsky CE, Sasson M, Beny L, Weinreb M,
Vardimon AD. Periodontal healing following orthodon-
tic movement of rat molars with intact versus dam-
aged periodontia towards a bony defect. Eur J Orthod
2007;29:338-344.
49. Vanarsdall RL. Orthodontics and periodontal therapy.
Periodontol 2000 1995;9:132-149.
50. da Silva VC, Cirelli CC, Ribeiro FS, et al. Intrusion of teeth
with class III furcation: A clinical, histologic and histomet-
ric study in dogs. J Clin Periodontol 2008;35:807-816.
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